Live from #AACR25: Alexander Anderson, PhD, (Sandy Anderson) leads the Adaptive Therapy from Board to Bench to Bedside and Back Again symposium. He shares how evolution-inspired treatment strategies like adaptive therapy can optimize drug use, delay resistance and improve outcomes

Insights shared at #AACR25 by Sabeen Ahmed about an #AI-driven tool to improve diagnosis and treatment of cancer cachexia! #MoffittAACR25

x.com/i/article/1917…

I'd be remiss if I didn't give a shoutout to the AACR Comms and PR team for being wonderful hosts to us in Chicago this week. They kept us well fed and well informed of all the big news of the day and helped us provide so much great content on the Moffitt Cancer Center feed.

What an incredible honor to have a global authority in urologic oncology and master surgical oncologist Prof Axel Heidenreich as our Moffitt GU Onc visiting professor. Thank you my friend and looking forward to seeing you soon Moffitt Urologic Oncology Fellowship Global Society of Rare GU Tumors

x.com/i/article/1919…

Just published in Nature Cancer: New #LungCancer study highlights challenges and opportunities for TIL therapy Ben Creelan, MD Stand Up To Cancer Moffitt Cancer Center moffitt.org/newsroom/news-…

First report on TIL therapy resistance in lung cancer! 📰 👉nature.com/articles/s4301… We show subclonal neoantigens are lost on progression; & antigen-specific TIL decay in non-responders. Proud of our team, and thanks to Stand Up To Cancer for funding! Nature Cancer @moffittnews

x.com/i/article/1920…

x.com/i/article/1923…

Congrats W. Gregory Sawyer! Much deserved.

Episode 2️⃣ of #TheImmunoVerse podcast is live! Check it out now on your favorite podcast platform! 🎙️

Very grateful any time one of our Moffitt Cancer Center patients trusts me to share their story. For #MelanomaAwarenessMonth I spoke with Mary Margaret Braddock about her journey and the importance of research and clinical trials. Melanoma Research Foundation Nikhil Khushalani moffitt.org/endeavor/archi…

Kicking off our #ASCO25 press program coverage to get your weekend started!

New large observational study from #ASCO25 shows the ⬇️ in cancer incidence and all cause mortality. Moffitt Cancer Center MoffittGYNONC we're exploring how these drugs are playing a role in secondary and tertiary prevention of #gyn cancers!

#GLP1 agonists are ⬇️ cancers linked to obesity #ASCO25. By inadvertently ⬇️ appetite and modifying diet, they're also modifying rates of cancers associated with variations in diet. MoffittGYNONC we're seeing if using them after cancer treatment also helps.

🚨 Exciting News! 🚨 Just down the street from Moffitt's new Speros Campus, our Mobile Lung Screening Program is providing essential lung screenings to the Angeline Community — and it’s happening on June 6th! 🌟 This beautiful community is clearly taking their health seriously,

Before #ASCO25, Dr. Marilyn Bui (Dr. Bui Pathologist🌼) highlights how AI is transforming pathology and precision oncology. By improving accuracy and consistency in HER2 breast cancer testing, #AI helps bridge gaps in care, especially where resources are limited. This research

I had the privilege of showing off the progress of the Moffitt Discovery and Innovation Center at SPEROS FL to a group of pioneering faculty. It’s been a real labor of love! Thank you to TKD, Whiting Turner, and Hammes for bringing the vision to life! Can’t wait to make new

Thanks to Elsa Renee Flores for hosting a wonderful tour of the Discovery and Innovation Center. Very exciting to see the vision come to life!